Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.
Official Title
Childhood Liver Disease Research Network (ChiLDReN): A Prospective Database of Infants With Cholestasis
Quick Facts
Study Start:2004-04-21
Study Completion:2029-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
Children's Hospital Los Angeles
Los Angeles, California, 90027
United States
University of California
San Francisco, California, 94143
United States
Children's Hospital Colorado
Aurora, Colorado, 80045
United States
Children's Healthcare of Atlanta - Emory University
Atlanta, Georgia, 30322
United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60614
United States
Riley Hospital for Children
Indianapolis, Indiana, 46202
United States
Johns Hopkins School of Medicine
Baltimore, Maryland, 21287
United States
Washington University School of Medicine
Saint Louis, Missouri, 63110
United States
Mount Sinai Medical Center
New York, New York, 10029
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104
United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224
United States
Baylor College of Medicine
Houston, Texas, 77030
United States
University of Utah
Salt Lake City, Utah, 84113
United States
Seattle Children's Hospital
Seattle, Washington, 98105
United States
Collaborators and Investigators
Sponsor: Arbor Research Collaborative for Health
- Saul Karpen, MD, PhD, STUDY_CHAIR, Children's Healthcare of Atlanta - Emory University
- Ed Doo, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- John Magee, MD, PRINCIPAL_INVESTIGATOR, University of Michigan Medical Center, Ann Arbor
- Lisa Henn, PhD, PRINCIPAL_INVESTIGATOR, Arbor Research Collaborative of Health
- Averell Sherker, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2004-04-21
Study Completion Date2029-05
Study Record Updates
Study Start Date2004-04-21
Study Completion Date2029-05
Terms related to this study
Additional Relevant MeSH Terms
- Biliary Atresia
- Neonatal Cholestasis